BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kondej M, Stępnicki P, Kaczor AA. Multi-Target Approach for Drug Discovery against Schizophrenia. Int J Mol Sci 2018;19:E3105. [PMID: 30309037 DOI: 10.3390/ijms19103105] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Kondej M, Wróbel TM, Silva AG, Stępnicki P, Koszła O, Kędzierska E, Bartyzel A, Biała G, Matosiuk D, Loza MI, Castro M, Kaczor AA. Synthesis, pharmacological and structural studies of 5-substituted-3-(1-arylmethyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as multi-target ligands of aminergic GPCRs. European Journal of Medicinal Chemistry 2019;180:673-89. [DOI: 10.1016/j.ejmech.2019.07.050] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
2 Gao L, Hao C, Ma R, Chen J, Zhang G, Chen Y. Synthesis and biological evaluation of a new class of multi-target heterocycle piperazine derivatives as potential antipsychotics. RSC Adv 2021;11:16931-41. [PMID: 35479681 DOI: 10.1039/d1ra02426d] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Ferdinand JM, Peters KZ, Yavas E, Young AMJ. Modulation of stimulated dopamine release in rat nucleus accumbens shell by GABA in vitro: Effect of sub-chronic phencyclidine pretreatment. J Neurosci Res 2021;99:1885-901. [PMID: 33848365 DOI: 10.1002/jnr.24843] [Reference Citation Analysis]
4 Apaydın S, Török M. Sulfonamide derivatives as multi-target agents for complex diseases. Bioorganic & Medicinal Chemistry Letters 2019;29:2042-50. [DOI: 10.1016/j.bmcl.2019.06.041] [Cited by in Crossref: 52] [Cited by in F6Publishing: 32] [Article Influence: 17.3] [Reference Citation Analysis]
5 Sherif MA, Neymotin SA, Lytton WW. In silico hippocampal modeling for multi-target pharmacotherapy in schizophrenia. NPJ Schizophr 2020;6:25. [PMID: 32958782 DOI: 10.1038/s41537-020-00109-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Miyazaki T, Nakajima W, Hatano M, Shibata Y, Kuroki Y, Arisawa T, Serizawa A, Sano A, Kogami S, Yamanoue T, Kimura K, Hirata Y, Takada Y, Ishiwata Y, Sonoda M, Tokunaga M, Seki C, Nagai Y, Minamimoto T, Kawamura K, Zhang MR, Ikegaya N, Iwasaki M, Kunii N, Kimura Y, Yamashita F, Taguri M, Tani H, Nagai N, Koizumi T, Nakajima S, Mimura M, Yuzaki M, Kato H, Higuchi M, Uchida H, Takahashi T. Visualization of AMPA receptors in living human brain with positron emission tomography. Nat Med 2020;26:281-8. [PMID: 31959988 DOI: 10.1038/s41591-019-0723-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
7 Czopek A, Partyka A, Bucki A, Pawłowski M, Kołaczkowski M, Siwek A, Głuch-Lutwin M, Koczurkiewicz P, Pękala E, Jaromin A, Tyliszczak B, Wesołowska A, Zagórska A. Impact of N-Alkylamino Substituents on Serotonin Receptor (5-HTR) Affinity and Phosphodiesterase 10A (PDE10A) Inhibition of Isoindole-1,3-dione Derivatives. Molecules 2020;25:E3868. [PMID: 32854402 DOI: 10.3390/molecules25173868] [Reference Citation Analysis]
8 Sobczuk P, Łomiak M, Cudnoch-Jędrzejewska A. Dopamine D1 Receptor in Cancer. Cancers (Basel) 2020;12:E3232. [PMID: 33147760 DOI: 10.3390/cancers12113232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhou J, Wu JH. Binding-Site Match Maker (BSMM): A Computational Method for the Design of Multi-Target Ligands. Molecules 2020;25:E1821. [PMID: 32316104 DOI: 10.3390/molecules25081821] [Reference Citation Analysis]
10 Koszła O, Targowska-Duda KM, Kędzierska E, Kaczor AA. In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia. Biomolecules 2020;10:E160. [PMID: 31963851 DOI: 10.3390/biom10010160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Kaczor AA, Targowska-Duda KM, Silva AG, Kondej M, Biała G, Castro M. N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1H- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic. Biomolecules 2020;10:E349. [PMID: 32102432 DOI: 10.3390/biom10020349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Carroll MJ, Garcia-Reyero N, Perkins EJ, Lauffenburger DA. Translatable pathways classification (TransPath-C) for inferring processes germane to human biology from animal studies data: example application in neurobiology. Integr Biol (Camb) 2021;13:237-45. [PMID: 34849940 DOI: 10.1093/intbio/zyab016] [Reference Citation Analysis]
13 Koola MM. Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of Schizophrenia. Mol Neuropsychiatry 2018;4:134-48. [PMID: 30643787 DOI: 10.1159/000494495] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
14 Koola MM. Alpha7 nicotinic-N-methyl-D-aspartate hypothesis in the treatment of schizophrenia and beyond. Hum Psychopharmacol 2021;36:1-16. [PMID: 32965756 DOI: 10.1002/hup.2758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gao L, Yang Z, Xiong J, Hao C, Ma R, Liu X, Liu BF, Jin J, Zhang G, Chen Y. Design, Synthesis and Biological Investigation of Flavone Derivatives as Potential Multi-Receptor Atypical Antipsychotics. Molecules 2020;25:E4107. [PMID: 32911828 DOI: 10.3390/molecules25184107] [Reference Citation Analysis]
16 Del Bello F, Ambrosini D, Bonifazi A, Newman AH, Keck TM, Giannella M, Giorgioni G, Piergentili A, Cappellacci L, Cilia A, Franchini S, Quaglia W. Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia. ACS Chem Neurosci 2019;10:2222-8. [PMID: 30609891 DOI: 10.1021/acschemneuro.8b00677] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
17 van Gastel J, Leysen H, Boddaert J, Vangenechten L, Luttrell LM, Martin B, Maudsley S. Aging-related modifications to G protein-coupled receptor signaling diversity. Pharmacol Ther 2021;223:107793. [PMID: 33316288 DOI: 10.1016/j.pharmthera.2020.107793] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Maini K, Hollier JW, Gould H, Bollich V, John LaForge J, Cornett EM, Edinoff AN, Kaye AM, Kaye AD. Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia. Health Psychol Res 2021;9:24932. [PMID: 34746489 DOI: 10.52965/001c.24932] [Reference Citation Analysis]
19 Verhellen J. Graph-based molecular Pareto optimisation. Chem Sci . [DOI: 10.1039/d2sc00821a] [Reference Citation Analysis]
20 Stone TW. Relationships and Interactions between Ionotropic Glutamate Receptors and Nicotinic Receptors in the CNS. Neuroscience 2021;468:321-65. [PMID: 34111447 DOI: 10.1016/j.neuroscience.2021.06.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Percelay S, Since M, Lagadu S, Freret T, Bouet V, Boulouard M. Antipsychotic lurasidone: Behavioural and pharmacokinetic data in C57BL/6 mice. Pharmacology Biochemistry and Behavior 2020;194:172933. [DOI: 10.1016/j.pbb.2020.172933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Antona A, Varalda M, Roy K, Favero F, Mazzucco E, Zuccalà M, Leo G, Soggia G, Bettio V, Tosi M, Gaggianesi M, Riva B, Reano S, Genazzani A, Manfredi M, Stassi G, Corà D, D'Alfonso S, Capello D. Dissecting the Mechanism of Action of Spiperone-A Candidate for Drug Repurposing for Colorectal Cancer. Cancers (Basel) 2022;14:776. [PMID: 35159043 DOI: 10.3390/cancers14030776] [Reference Citation Analysis]
23 Seifert R. Drugs for Treatment of Schizophrenia. Basic Knowledge of Pharmacology. Cham: Springer International Publishing; 2019. pp. 345-55. [DOI: 10.1007/978-3-030-18899-3_29] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Stępnicki P, Kondej M, Koszła O, Żuk J, Kaczor AA. Multi-targeted drug design strategies for the treatment of schizophrenia. Expert Opin Drug Discov 2021;16:101-14. [PMID: 32915109 DOI: 10.1080/17460441.2020.1816962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Seifert R, Schirmer B. A simple mechanistic terminology of psychoactive drugs: a proposal. Naunyn Schmiedebergs Arch Pharmacol 2020;393:1331-9. [PMID: 32535698 DOI: 10.1007/s00210-020-01918-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
26 Gao L, Hao C, Chen J, Ma R, Zheng L, Wu Q, Liu X, Liu BF, Zhang G, Chen Y, Jin J. Discovery of a new class of multi-target heterocycle piperidine derivatives as potential antipsychotics with pro-cognitive effect. Bioorg Med Chem Lett 2021;40:127909. [PMID: 33705900 DOI: 10.1016/j.bmcl.2021.127909] [Reference Citation Analysis]
27 Kaczor AA, Targowska-Duda KM, Stępnicki P, Silva AG, Koszła O, Kędzierska E, Grudzińska A, Kruk-Słomka M, Biała G, Castro M. N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a multi-target ligand. Neurochem Int 2021;146:105016. [PMID: 33722679 DOI: 10.1016/j.neuint.2021.105016] [Reference Citation Analysis]
28 Filimonov DA, Rudik AV, Dmitriev AV, Poroikov VV. Computer-Aided Estimation of Biological Activity Profiles of Drug-Like Compounds Taking into Account Their Metabolism in Human Body. Int J Mol Sci 2020;21:E7492. [PMID: 33050610 DOI: 10.3390/ijms21207492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Bonifazi A, Newman AH, Keck TM, Gervasoni S, Vistoli G, Del Bello F, Giorgioni G, Pavletić P, Quaglia W, Piergentili A. Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D3 Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders. ACS Chem Neurosci 2021;12:3638-49. [PMID: 34529404 DOI: 10.1021/acschemneuro.1c00368] [Reference Citation Analysis]
30 Karunakaran KB, Chaparala S, Ganapathiraju MK. Potentially repurposable drugs for schizophrenia identified from its interactome. Sci Rep 2019;9:12682. [PMID: 31481665 DOI: 10.1038/s41598-019-48307-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]